Rapid molecular tests for women's health
Raised to date
$5.3M
of $6M offered across 1 Form D filing
Nanopath Inc is a pioneering molecular diagnostics company headquartered in Cambridge, Massachusetts. The company is dedicated to revolutionizing traditional medical testing approaches, particularly in the domain of women's health, by developing rapid and accurate diagnostic solutions.
Nanopath is distinguished by its ability to deliver detailed diagnostic information during a single medical visit, thus significantly enhancing the efficiency and effectiveness of healthcare delivery in women's health.
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Feb 6, 2025 | Debt | $5.3M/ $6M | Form D |
Diagnostic technology
Nanopath's molecular diagnostic technology offers rapid and comprehensive testing solutions designed specifically for women's health. This platform allows healthcare providers to obtain clinically actionable insights quickly, aiding in more prompt and accurate health assessments.
Built for
Healthcare providers in women's health
